Investment in blood cancer research has saved nearly 26 million years of life, but disparities remain

Over the past 75 years, advances in the treatment of major blood cancers have saved more than 25 million years of life in the United States, according to results of an analysis led by researchers at Blood Cancer United and published in Blood Advances. But the gains have not reached everyone equally: survival progress remains limited for people diagnosed with acute myeloid leukemia (AML) and for Black individuals across most major blood cancer types.

Read it at Medical Xpress ↗

← Front page